USA - Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products

The Food and Drug Administration (FDA) is proposing a tobacco product standard that would establish a limit of N-Nitrosonornicotine (NNN) in finished smokeless tobacco products. FDA is taking this action because NNN is a potent carcinogenic agent found in smokeless tobacco products and is a major contributor to the elevated cancer risks associated with smokeless tobacco use. Because products with higher NNN levels pose higher risks of cancer, FDA finds that establishing a NNN limit in finished smokeless tobacco products is appropriate for the protection of the public health.

Proposed date of adoption: To be determined

Proposed date of entry into force: To be determined

Final date for comments: 10 April 2017

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.